{
    "source": {
        "id": "the-verge",
        "name": "The Verge"
    },
    "author": "Nicole Wetsman",
    "title": "Why we\u2019re still relying on a century-old strategy to treat COVID-19",
    "description": "Doctors are treating patients with blood from people who have already recovered from a coronavirus infection. The antibodies in the blood may help them recover. The therapy has also been used for measles, the flu, and diphtheria. It\u2019s a stop-gap before there\u2019\u2026",
    "url": "https://www.theverge.com/2020/4/13/21216513/plasma-blood-coronavirus-treament-drug-development-antibodies",
    "urlToImage": "https://cdn.vox-cdn.com/thumbor/oGreHsiJVUKt2pB58bUBOPSFGXI=/0x358:5000x2976/fit-in/1200x630/cdn.vox-cdn.com/uploads/chorus_asset/file/19895569/1209156481.jpg.jpg",
    "publishedAt": "2020-04-13T19:15:46Z",
    "content": "Science is moving fast, but its still not fast enough\r\nPhoto by Adisorn Chabsungnoen / SOPA Images / LightRocket via Getty Images\r\nCOVID-19 research is advancing at an unprecedented speed, but one strategy doctors are leaning on to treat COVID-19 patients loo\u2026 [+5192 chars]"
}